Predictive oncology appoints pamela bush, ph.d., mba, as chief business officer

Eagan, minn., feb. 03, 2023 (globe newswire) -- predictive oncology inc. (nasdaq: poai) is pleased to announce the appointment of pamela bush, ph.d., mba, as chief business officer. dr. bush will lead all business development, partnering and growth strategies for predictive oncology.

POAI Ratings Summary

POAI Quant Ranking